Literature DB >> 17385694

Woodchuck dendritic cells generated from peripheral blood mononuclear cells and transduced with recombinant human adenovirus serotype 5 induce antigen-specific cellular immune responses.

Laura Ochoa-Callejero1, Pedro Berraondo, Julien Crettaz, Cristina Olagüe, Africa Vales, Juan Ruiz, Jesús Prieto, Bud C Tennant, Stephan Menne, Gloria González-Aseguinolaza.   

Abstract

Woodchucks infected with the woodchuck hepatitis virus (WHV) is the best available animal model for testing the immunotherapeutic effects of dendritic cells (DCs) in the setting of a chronic infection, as woodchucks develop a persistent infection resembling that seen in humans infected with the hepatitis B virus. In the present study, DCs were generated from woodchuck peripheral blood mononuclear cells (wDCs) in the presence of human granulocyte macrophage colony-stimulating factor (hGM-CSF) and human interleukin 4 (hIL-4). After 7 days of culture, cells with morphology similar to DCs were stained positively with a cross-reactive anti-human CD86 antibody. Functional analysis showed that uptake of FITC-dextran by wDCs was very efficient and was partially inhibited after LPS-induced maturation. Furthermore, wDCs stimulated allogenic lymphocytes and induced proliferation. Moreover, wDCs were transduced efficiently with a human adenovirus serotype 5 for the expression of beta-galactosidase. Following transduction and in vivo administration of such DCs into woodchucks, an antigen-specific cellular immune response was induced. These results demonstrate that wDCs can be generated from the peripheral blood. Following transfection with a recombinant adenovirus wDCs can be used as a feasible and effective tool for eliciting WHV-specific T-cell responses indicating their potential to serve as prophylactic and therapeutic vaccines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17385694     DOI: 10.1002/jmv.20808

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  2 in total

1.  Antigen-presenting cells transfected with Hsp65 messenger RNA fail to treat experimental tuberculosis.

Authors:  C D Rocha; A P F Trombone; J C C Lorenzi; L P Almeida; A F Gembre; E Padilha; S G Ramos; C L Silva; A A M Coelho-Castelo
Journal:  Braz J Med Biol Res       Date:  2012-09-18       Impact factor: 2.590

2.  Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer.

Authors:  Yoshitaro Shindo; Shoichi Hazama; Yoshinari Maeda; Hiroto Matsui; Michihisa Iida; Nobuaki Suzuki; Kiyoshi Yoshimura; Tomio Ueno; Shigefumi Yoshino; Kohei Sakai; Yutaka Suehiro; Takahiro Yamasaki; Yuji Hinoda; Masaaki Oka
Journal:  J Transl Med       Date:  2014-06-19       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.